Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma

被引：1
|
作者：
Jackson, David [1 ,2 ]
Roxas, Cris [1 ]
Thompson, Louise [1 ]
Fernandes, Mariana [1 ]
Green, Linda [1 ]
Kavanagh, Joanne [1 ]
Nanzer-Kelly, Alexandra [1 ]
D'Ancona, Grainne [1 ]
Kent, Brian [1 ]
机构：
[1] Guys & St Thomas NHS Trust, Guys Severe Asthma Ctr, London, England
[2] Kings Coll London, London, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; Severe asthma; Exacerbation;
D O I：
10.1183/13993003.congress-2019.PA2527
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2527
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma
    Nair, Parameswaran
    Wenzel, Sally
    Rabe, Klaus F.
    Bourdin, Arnaud
    Lugogo, Njira L.
    Kuna, Piotr
    Barker, Peter
    Sproule, Stephanie
    Ponnarambil, Sandhia
    Goldman, Mitchell
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25): : 2448 - 2458
  • [2] Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis
    Padoan, Roberto
    Bianchi, Fulvia Chieco
    Marchi, Maria Rita
    Cazzador, Diego
    Felicetti, Mara
    Emanuelli, Enzo
    Vianello, Andrea
    Nicolai, Piero
    Doria, Andrea
    Schiavon, Franco
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (09): : 3225 - +
  • [3] Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
    Bel, Elisabeth H.
    Wenzel, Sally E.
    Thompson, Philip J.
    Prazma, Charlene M.
    Keene, Oliver N.
    Yancey, Steven W.
    Ortega, Hector G.
    Pavord, Ian D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1189 - 1197
  • [4] Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
    Kavanagh, Joanne E.
    Hearn, Andrew P.
    Dhariwal, Jaideep
    d'Ancona, Grainne
    Douiri, Abdel
    Roxas, Cris
    Fernandes, Mariana
    Green, Linda
    Thomson, Louise
    Nanzer, Alexandra M.
    Kent, Brian D.
    Jackson, David J.
    CHEST, 2021, 159 (02) : 496 - 506
  • [5] Real-world clinical remission of severe asthma with benralizumab in Spanish adults with severe asthma
    Martinez-Moragon, Eva
    Chiner, Eusebi
    Mogrovejo, Alexandra Suliana
    Cervera, Marta Palop
    Tortajada, Inmaculada Lluch
    Enrique, Ignacio Boira
    Vera, Andres Fernando Sanchez
    JOURNAL OF ASTHMA, 2024, 61 (10) : 1190 - 1204
  • [6] REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Chupp, Geoffrey
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Almonacid, Carlos
    Welte, Tobias
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Maxwell, Aoife
    Price, Robert G.
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10): : 2646 - 2656
  • [7] Glucocorticoid Sparing of Benralizumab in Asthma REPLY
    Nair, Parameswaran
    Barker, Peter
    Goldman, Mitchell
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (12): : 1205 - 1205
  • [8] Real-world treatment patterns of benralizumab therapy for patients with severe asthma
    Gendron, Alain
    Sriskandarajah, Niroshan
    Johnston, Karissa
    Osenenko, Kathy M.
    Noorduyn, Stephen G.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [9] REAL-WORLD 1 YEAR EFFECTIVENESS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Kavanagh, J.
    Roxas, C.
    Thomson, L.
    Fernandes, M.
    Green, L.
    d'Ancona, G.
    Dhariwal, J.
    Nanzer, A. M.
    Kent, B. D.
    Jackson, D. J.
    THORAX, 2019, 74 : A138 - A138
  • [10] Real-World Effectiveness Study of Benralizumab for Severe Eosinophilic Asthma: ZEPHYR 2
    Carstens, Donna
    Maselli, Diego J.
    Mu, Fan
    Cook, Erin E.
    Yang, Danni
    Young, Joshua A.
    Betts, Keith A.
    Genofre, Eduardo
    Chung, Yen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (07): : 2150 - +
12345